WASHINGTON, May 23 -- Editas Medicine Inc. (EDIT), Cambridge, Mass., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest held by EVP and Chief Financial Officer Erick Lucera, Cambridge.
On May 20 the action involved disposition of 22337 Common Stocks. Lucera owns 116829 Common Stocks directly.
Disclaimer: Curated by HT Syndication....